NHK




 

Japanese scientist Sakaguchi Shimon, a co-winner of this year's Nobel Prize in Physiology or Medicine, has spoken about his work at a news conference in Stockholm.

He was joined by the two American researchers who shared the prize at the event hosted by the Nobel Foundation on Saturday.

Sakaguchi said the regulatory T cells he discovered have broad potential applications for various immune disorders, autoimmune diseases, and allergies.

He said that a certain percentage of cancer patients could become treatable with immunotherapy by improving the methods for controlling regulatory T cells.

Sakaguchi said he hopes the award will raise societal awareness of the importance of medical research, and he hopes that governments will realize the importance of supporting basic research.